{"id":6571,"date":"2024-08-21T14:26:06","date_gmt":"2024-08-21T12:26:06","guid":{"rendered":"https:\/\/stiftkgj.no\/?post_type=senter&#038;p=6571"},"modified":"2025-06-22T14:24:44","modified_gmt":"2025-06-22T12:24:44","slug":"for-myeloid-blood-cancer","status":"publish","type":"senter","link":"https:\/\/stiftkgj.no\/en\/senter\/for-myeloid-blood-cancer\/","title":{"rendered":"K.G. Jebsen Centre for Myeloid Blood Cancer"},"content":{"rendered":"<div class=\"wpb-content-wrapper\"><p>[vc_row css=&#8221;.vc_custom_1651580050061{margin-right: 0px !important;margin-left: 0px !important;background-image: url(https:\/\/stiftkgj.no\/wp-content\/uploads\/2022\/04\/Topp-bilde-2.jpg?id=427) !important;background-position: center !important;background-repeat: no-repeat !important;background-size: cover !important;}&#8221;][vc_column]<div class=\"spacer-5830a5ea62c1f2880975a2ceab4a96be2\" style=\"\"><\/div><style>@media (min-width: 320px) { .spacer-5830a5ea62c1f2880975a2ceab4a96be2{ height: 200px;}}@media (min-width: 767px) { .spacer-5830a5ea62c1f2880975a2ceab4a96be2{ height: 200px;}}@media (min-width: 979px) { .spacer-5830a5ea62c1f2880975a2ceab4a96be2{ height: 300px;}}@media (min-width: 1200px) { .spacer-5830a5ea62c1f2880975a2ceab4a96be2{ height: 300px;}}<\/style>[\/vc_column][\/vc_row][vc_row el_class=&#8221;article-white&#8221; css=&#8221;.vc_custom_1649536549777{margin-right: 0px !important;margin-left: 0px !important;}&#8221;][vc_column][vc_row_inner][vc_column_inner][vc_separator color=&#8221;chino&#8221; border_width=&#8221;2&#8243;]<div class=\"header left  \"><h1 class=\"font-size-sm\" title=\"K.G. Jebsen Center for for Myeloid Blood Cancer\" style=\"color:#0054a2\">K.G. Jebsen Center for for Myeloid Blood Cancer<\/h1><\/div>[\/vc_column_inner][\/vc_row_inner][vc_row_inner][vc_column_inner width=&#8221;3\/4&#8243;]\n\t\t\t<figure  class=\"standard-image left no-caption\">\n\t\t\t\t<img loading=\"lazy\" decoding=\"async\" width=\"1920\" height=\"1138\" src=\"https:\/\/stiftkgj.no\/wp-content\/uploads\/2024\/08\/BT-Gjertsen-foto-CCBIO-UiB-Ingvild-Festervoll-Melien-1920x1138-1-e1724248467900.jpg\" class=\"attachment-full size-full\" alt=\"\" \/>\n\t\t\t\t\n\t\t\t<\/figure>[vc_column_text css=&#8221;&#8221;]<\/p>\n<div id=\"tw-container\" class=\"nev7se\" data-cp=\"1\" data-nnttsvi=\"1\" data-ntl-fpwrite=\"true\" data-sletp=\"false\" data-sm=\"1\" data-ssbp=\"false\" data-sugg-time=\"500\" data-sugg-url=\"https:\/\/clients1.google.com\/complete\/search\" data-uilc=\"no\" data-vil=\",af,af-ZA,am,am-ET,ar-EG,ar-AE,ar-KW,ar-QA,ar,ar-IL,ar-JO,ar-LB,ar-PS,az,az-AZ,bg,bg-BG,bn,bn-BD,bn-IN,ca,ca-es,cs,cs-CZ,de,de-DE,de-CH,de-AT,de-LI,en,en-US,en-CA,en-AU,en-NZ,en-GB,en-IN,en-KE,en-TZ,en-NG,en-GH,en-PH,en-ZA,es,es-ES,es-AR,es-UY,es-419,es-BO,es-CL,es-CR,es-CO,es-DO,es-EC,es-GT,es-HN,es-NI,es-PA,es-PE,es-PR,es-PY,es-SV,es-VE,es-MX,es-US,eu,eu-ES,fi,fi-FI,fr,fr-FR,fr-CH,fr-BE,gl,gl-ES,gu,gu-IN,he,he-IL,iw,iw-IL,hu,hu-HU,hy,hy-AM,id,id-ID,is,is-IS,it,it-IT,it-CH,ja,ja-JP,jv,jv-ID,ka,ka-GE,km,km-KH,kn,kn-IN,ko,ko-KR,la,lo,lo-LA,lv,lv-LV,ml,ml-IN,mr,mr-IN,ms,ms-MY,nl,nl-NL,nb,nb-NO,ne,ne-NP,pl,pl-PL,pt,pt-BR,pt-PT,ro,ro-RO,ru,ru-RU,si-LK,sk,sk-SK,sr,sr-RS,su,su-ID,sv,sv-SE,sw,sw-TZ,sw-KE,ta,ta-IN,ta-SG,ta-LK,ta-MY,te,te-IN,tr,tr-TR,ur,ur-PK,ur-IN,yue,yue-HK,yue-Hant-HK,zh-HK,zh,zh-CN,zh-cmn,zh-cmn-CN,zh-Hans,zh-Hans-CN,zh-cmn-Hans,zh-cmn-Hans-CN,cmn-CN,cmn-Hans,cmn-Hans-CN,zh-TW,zh-Hant-TW,cmn-TW,cmn-Hant-TW,zh-cmn-TW,zh-cmn-Hant-TW,zu,zu-ZA,hi,hi-IN,tl,tl-PH,pa,pa-IN\">\n<div id=\"tw-ob\" class=\"tw-src-ltr\">\n<div class=\"oSioSc\">\n<div id=\"tw-target\">\n<div id=\"kAz1tf\" class=\"g9WsWb PZPZlf\" data-attrid=\"tw-targetArea\" data-entityname=\"Google Translate\">\n<div id=\"tw-target-text-container\" class=\"tw-ta-container tw-nfl\" tabindex=\"0\" role=\"text\">\n<p id=\"tw-target-text\" class=\"tw-data-text tw-text-large tw-ta\" dir=\"ltr\" data-placeholder=\"Oversettelse\" data-ved=\"2ahUKEwjTwcuD_ISOAxV3ExAIHXNVCKsQ3ewLegQICRAV\" aria-label=\"Oversatt tekst: Cancer affects approximately 30,000 people in Norway each year, and more than 10 million people worldwide die from cancer each year. Cancer is now the leading cause of death globally and is increasing rapidly with increasing life expectancy. Treatment for most aggressive cancers is inadequate. Patients who start treatment for blood cancer such as acute myeloid leukemia usually receive standard therapy that does not always work on the patient's cancer cells, but doctors do not discover this until a few weeks later. The main goal of the new K.G. Jebsen Center for Myeloid Blood Cancer (CMYC) is to develop diagnostics at the single-cell level that reveals response to treatment after hours and days, and use this information to optimize or replace the planned treatment. The researchers want to develop diagnostics and treatment that closely follows the individual cancer cell. At the same time, information can be obtained about other cells, immune cells and support cells that affect the treatment effect. Overall, one will then have information at the cellular level about the individual patient, which will allow for more accurate and dynamic tailoring of treatment.\">Cancer affects approximately 30,000 people in Norway each year, and more than 10 million people worldwide die from cancer each year. Cancer is now the leading cause of death globally and is increasing rapidly with increasing life expectancy. Treatment for most aggressive cancers is inadequate. Patients who start treatment for blood cancer such as acute myeloid leukemia usually receive standard therapy that does not always work on the patient&#8217;s cancer cells, but doctors do not discover this until a few weeks later. The main goal of the new K.G. Jebsen Center for Myeloid Blood Cancer (CMYC) is to develop diagnostics at the single-cell level that reveals response to treatment after hours and days, and use this information to optimize or replace the planned treatment. The researchers want to develop diagnostics and treatment that closely follows the individual cancer cell. At the same time, information can be obtained about other cells, immune cells and support cells that affect the treatment effect. Overall, one will then have information at the cellular level about the individual patient, which will allow for more accurate and dynamic tailoring of treatment.<\/p>\n<div class=\"wpb_text_column wpb_content_element\">\n<div class=\"wpb_wrapper\">\n<div id=\"tw-container\" class=\"nev7se\" data-cp=\"1\" data-nnttsvi=\"1\" data-ntl-fpwrite=\"true\" data-sletp=\"false\" data-sm=\"1\" data-ssbp=\"false\" data-sugg-time=\"500\" data-sugg-url=\"https:\/\/clients1.google.com\/complete\/search\" data-uilc=\"no\" data-vil=\",af,af-ZA,am,am-ET,ar-EG,ar-AE,ar-KW,ar-QA,ar,ar-IL,ar-JO,ar-LB,ar-PS,az,az-AZ,bg,bg-BG,bn,bn-BD,bn-IN,ca,ca-es,cs,cs-CZ,de,de-DE,de-CH,de-AT,de-LI,en,en-US,en-CA,en-AU,en-NZ,en-GB,en-IN,en-KE,en-TZ,en-NG,en-GH,en-PH,en-ZA,es,es-ES,es-AR,es-UY,es-419,es-BO,es-CL,es-CR,es-CO,es-DO,es-EC,es-GT,es-HN,es-NI,es-PA,es-PE,es-PR,es-PY,es-SV,es-VE,es-MX,es-US,eu,eu-ES,fi,fi-FI,fr,fr-FR,fr-CH,fr-BE,gl,gl-ES,gu,gu-IN,he,he-IL,iw,iw-IL,hu,hu-HU,hy,hy-AM,id,id-ID,is,is-IS,it,it-IT,it-CH,ja,ja-JP,jv,jv-ID,ka,ka-GE,km,km-KH,kn,kn-IN,ko,ko-KR,la,lo,lo-LA,lv,lv-LV,ml,ml-IN,mr,mr-IN,ms,ms-MY,nl,nl-NL,nb,nb-NO,ne,ne-NP,pl,pl-PL,pt,pt-BR,pt-PT,ro,ro-RO,ru,ru-RU,si-LK,sk,sk-SK,sr,sr-RS,su,su-ID,sv,sv-SE,sw,sw-TZ,sw-KE,ta,ta-IN,ta-SG,ta-LK,ta-MY,te,te-IN,tr,tr-TR,ur,ur-PK,ur-IN,yue,yue-HK,yue-Hant-HK,zh-HK,zh,zh-CN,zh-cmn,zh-cmn-CN,zh-Hans,zh-Hans-CN,zh-cmn-Hans,zh-cmn-Hans-CN,cmn-CN,cmn-Hans,cmn-Hans-CN,zh-TW,zh-Hant-TW,cmn-TW,cmn-Hant-TW,zh-cmn-TW,zh-cmn-Hant-TW,zu,zu-ZA,hi,hi-IN,tl,tl-PH,pa,pa-IN\">\n<div id=\"tw-ob\" class=\"tw-src-ltr\">\n<div class=\"oSioSc\">\n<div id=\"tw-target\">\n<div id=\"kAz1tf\" class=\"g9WsWb PZPZlf\" data-attrid=\"tw-targetArea\" data-entityname=\"Google Translate\">\n<div id=\"tw-target-text-container\" class=\"tw-ta-container tw-nfl\" tabindex=\"0\" role=\"text\">\n<p id=\"tw-target-text\" class=\"tw-data-text tw-text-large tw-ta\" dir=\"ltr\" data-placeholder=\"Oversettelse\" data-ved=\"2ahUKEwjTwcuD_ISOAxV3ExAIHXNVCKsQ3ewLegQICRAV\" aria-label=\"Oversatt tekst: The center will also increase the offer for leukemia patients to participate in treatment studies, and the center will work to strengthen Norwegian and Nordic cooperation on blood cancer research through new treatment studies. Treatment of leukemia has previously shown the way in the development of targeted treatment with chemotherapy tablets, and advanced immunotherapy and cell therapy. The center will build on these experiences and the researchers hope that the final delivery will be new diagnostics and groundbreaking treatments that can make a clear difference for people with cancer, says center director Bj\u00f8rn Tore Gjertsen. Gjertsen has two other researchers in the leadership group: deputy head professor Simona Chera, Clinical Institute 2, UiB, and professor Eivind Dale Valen, Department of Life Sciences, UiO. Center director Bj\u00f8rn Tore Gjertsen Leadership group Simona Chera \u2013 deputy head Eivind Valen, UiO\"><span class=\"Y2IQFc\" lang=\"en\">The center will also increase the offer for leukemia patients to participate in treatment studies, and the center will work to strengthen Norwegian and Nordic cooperation on blood cancer research through new treatment studies. Treatment of leukemia has previously shown the way in the development of targeted treatment with chemotherapy tablets, and advanced immunotherapy and cell therapy. The center will build on these experiences and the researchers hope that the final delivery will be new diagnostics and groundbreaking treatments that can make a clear difference for people with cancer, says center director Bj\u00f8rn Tore Gjertsen. Gjertsen has two other researchers in the leadership group:\u00a0 <\/span><span class=\"Y2IQFc\" lang=\"en\">deputy head professor Simona Chera, Clinical Institute 2, UiB, and professor Eivind Dale Valen, Department of Life Sciences, UiO.<\/span><\/p>\n<p><strong>Center director<\/strong><br \/>\nBj\u00f8rn Tore Gjertsen<br \/>\n<strong>Leadership group:<br \/>\n<\/strong>Simona Chera \u2013 deputy head<br \/>\nEivind Valen, UiO<\/p>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<p>[\/vc_column_text]<div class=\"header left  \"><h2 class=\"font-size-sm\" title=\"Media\" >Media<\/h2><\/div><div class=\"external-links-container light-blue\"><ul class=\"external-links\"><li class=\"inner-item\"><i class=\"fa fa-external-link\"><\/i><a href=\"https:\/\/www.tv2.no\/nyheter\/innenriks\/haper-a-revolusjonere-kreftbehandlingen\/16651993\/\" target=\"_blank\" rel=\"noopener\">TV2<\/a><span class=\"description\">H\u00e5per \u00e5 revolusjonere kreftbehandlingen<\/span><span class=\"date\">10.05.2024<\/span><\/li><li class=\"inner-item\"><i class=\"fa fa-external-link\"><\/i><a href=\"https:\/\/www.uib.no\/med\/168382\/satser-storstilt-p%C3%A5-bedre-behandling-av-blodkreft\" target=\"_blank\" rel=\"noopener\">Universitetet i Bergen<\/a><span class=\"description\">Satser storstilt p\u00e5 bedre behandling av blodkreft<\/span><span class=\"date\">09.02.2024<\/span><\/li><\/ul><\/div>[\/vc_column_inner][vc_column_inner width=&#8221;1\/4&#8243;]<div class=\"infobox light-brown\"><h3>The Center in brief<\/h3>\n<div class=\"wpb_text_column wpb_content_element \">\n<div class=\"wpb_wrapper\">\n<p>Leader: <a href=\"https:\/\/www4.uib.no\/finn-ansatte\/Bj%C3%B8rn.Tore.Gjertsen\" target=\"_blank\" rel=\"noopener\">Bj\u00f8rn Tore Gjertsen<\/a><br \/>\nCenter period 2024-2029<br \/>\nHost institution: The University of Bergen<br \/>\nFunding 22.5 MNOK<br \/>\n<a href=\"https:\/\/cmyc.w.uib.no\/\" target=\"_blank\" rel=\"noopener\">Home page<\/a><\/p>\n<\/div>\n<\/div>\n<\/div><div class=\"infobox light-brown\"><h3>Contact information<\/h3>\n<div class=\"width-container\">\n<div class=\"width-container\">\n<p><strong>Contact informasjon<\/strong><\/p>\n<p><a href=\"mailto:post@k2.uib.no\">c-myc@uib.no<\/a><br \/>\n+47 55973059<\/p>\n<p><strong>Visiting address:<br \/>\n<\/strong><\/p>\n<p>Haukeland University Hospital<br \/>\nLab building 3rd floor<br \/>\nOur laboratories are visible from the lobby outside the bloodbank. Our offices are right behind the blood bank<\/p>\n<\/div>\n<div class=\"width-container\">\n<p><strong>Postal address:<br \/>\n<\/strong><\/p>\n<p>Universitetet i Bergen<br \/>\nKlinisk institutt 2<br \/>\nPostboks 7804<br \/>\nNO-5020 BERGEN<br \/>\nNORWAY<\/p>\n<\/div>\n<\/div>\n<\/div>[vc_single_image image=&#8221;6563&#8243; img_size=&#8221;medium&#8221; add_caption=&#8221;yes&#8221; css=&#8221;&#8221;][vc_single_image image=&#8221;6561&#8243; img_size=&#8221;medium&#8221; add_caption=&#8221;yes&#8221; css=&#8221;&#8221;][\/vc_column_inner][\/vc_row_inner]<div class=\"spacer-19ba46bd32479517faefa95d8bc53e873425752342356\" style=\"\"><\/div><style>@media (min-width: 320px) { .spacer-19ba46bd32479517faefa95d8bc53e873425752342356{ height: 30px;}}@media (min-width: 767px) { .spacer-19ba46bd32479517faefa95d8bc53e873425752342356{ height: 30px;}}@media (min-width: 979px) { .spacer-19ba46bd32479517faefa95d8bc53e873425752342356{ height: 60px;}}@media (min-width: 1200px) { .spacer-19ba46bd32479517faefa95d8bc53e873425752342356{ height: 60px;}}<\/style>[\/vc_column][\/vc_row][vc_row][vc_column][\/vc_column][\/vc_row][vc_row][vc_column][\/vc_column][\/vc_row]<\/p>\n<\/div>","protected":false},"excerpt":{"rendered":"<p>The new K.G. Jebsen Center for Myeloid Blood Cancer will develop diagnostics at the single cell level that reveals the cancer cells&#8217; response to treatment after a short time, and use this information to optimize patients&#8217; treatment. The center is led by professor at the University of Bergen and consultant at Haukeland University Hospital, Bj\u00f8rn Tore Gjertsen. [&#8230;]<\/p>\n<p><a class=\"btn btn-secondary vidiflex-read-more-link\" href=\"https:\/\/stiftkgj.no\/en\/senter\/for-myeloid-blood-cancer\/\">Read More&#8230;<\/a><\/p>\n","protected":false},"featured_media":6559,"template":"","categories":[32],"class_list":["post-6571","senter","type-senter","status-publish","has-post-thumbnail","hentry","category-medical-research"],"acf":[],"publishpress_future_workflow_manual_trigger":{"enabledWorkflows":[]},"_links":{"self":[{"href":"https:\/\/stiftkgj.no\/en\/wp-json\/wp\/v2\/senter\/6571","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/stiftkgj.no\/en\/wp-json\/wp\/v2\/senter"}],"about":[{"href":"https:\/\/stiftkgj.no\/en\/wp-json\/wp\/v2\/types\/senter"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/stiftkgj.no\/en\/wp-json\/wp\/v2\/media\/6559"}],"wp:attachment":[{"href":"https:\/\/stiftkgj.no\/en\/wp-json\/wp\/v2\/media?parent=6571"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/stiftkgj.no\/en\/wp-json\/wp\/v2\/categories?post=6571"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}